The new reporting schedule is intended to improve transparency and speed in detecting safety concerns.
The Food and Drug Administration has started publishing daily updates from the FDA Adverse Event Reporting System (FAERS), which tracks reports of side effects, medication errors, and product quality issues related to prescription drugs and biologics. This step eliminates long delays in public access to safety data, aiming for a faster and more transparent process.
“Adverse event reporting should be fast, seamless, and transparent,” said FDA Commissioner Marty Makary. “People who navigate the government’s clunky adverse event reporting websites should not have to wait months for that information to become public. We’re closing that waiting period and will continue to streamline the process from start to finish.”
This move is part of the FDA’s plan to modernize its safety monitoring systems and identify potential risks more quickly. The latest data is available on the FAERS Public Dashboard, and both healthcare professionals and consumers are encouraged to report adverse events through the FDA’s MedWatch program.
As the Lord Leads, Pray with Us…
- For Commissioner Makary as he manages the updates and modernization of the FDA’s safety monitoring systems.
- For FDA officials as they assess safety data related to adverse events from medications.
Sources: Food and Drug Administration
